SCHEMBL25015970

SCHEMBL25015970

CC(C)(C)OC(=O)NC(=N)c1ccc2cc(C(=O)N3CC[C@H](O)C3)n(Cc3cccc4ccccc34)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.38
▸ TSHR P16473 3/20 0.38
▸ CYP2C9 P11712 3/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SLC16A1 P53985 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CNR2 P34972 1/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ SLC6A4 P31645 2/20 0.34
▸ SLC6A3 Q01959 2/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ CTSS P25774 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ F10 P00742 3/20 0.34
▸ USP30 Q70CQ3 1/20 0.34
▸ PADI4 Q9UM07 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015739 1.00 CYP3A4 (0.38) CYP3A4TSHRCYP2C9CYP1A2CYP2C19
SCHEMBL25016295 0.91 USP30 (0.41) CYP3A4TSHRCYP2C9CYP1A2CYP2C19
SCHEMBL25016100 0.91 USP30 (0.41) CYP3A4TSHRCYP2C9CYP1A2CYP2C19
SCHEMBL25016101 0.90 HTR2C (0.44) CYP3A4TSHRCYP2C9CYP1A2CYP2C19
SCHEMBL25015964 0.88 CNR2 (0.39) CYP3A4TSHRCYP2C9CYP1A2CYP2C19
SCHEMBL25017943 0.86 ACHE (0.43) CYP3A4TSHRCYP2C9CYP1A2CYP2C19
SCHEMBL25016107 0.85 F10 (0.41) CNR2F10USP30NQO2F2
SCHEMBL21822737 0.84 CTSS (0.42) CTSSCTSKF10NQO2
SCHEMBL31689662 0.84 CTSS (0.42) CTSSCTSKF10NQO2
SCHEMBL28583314 0.84 USP30 (0.46) ACHEF10USP30F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 CYP3A4 1926/4885TSHR 4421/4885CYP2C9 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback